Makale
Tam Makale
Uluslararası
2012
Anti-Cyclic Citrullinated Peptide Frequency in Patients with Chronic Hepatitis C Virus Infection and Effect of Presence of Systemic Disease
EURASIAN JOURNAL OF MEDICINE
Cilt 44 · Sayı 3 · ss. 131–134 · 01.12.2012
Özet
Objective: Patients with chronic hepatitis C virus (HCV) infection may show a variety of rheumatic symptoms and signs. Anti-cyclic citrullinated peptide (anti-CCP) is widely used as as a marker, particularly for rheumatoid arthritis (RA), and may be positive in some diseases that also cause arthritis, such as systemic lupus erythematosus, familial Mediterranean fever, Behcet's disease, and psoriatic arthritis.
Sürdürülebilir Kalkınma Amaçları
-
SKA 3: Sağlıklı Bireyler
Atıf için künye
Albayrak, A., Dursun, H., Uyanık, M. H., & Cerrah, S. (2012). Anti-Cyclic Citrullinated Peptide Frequency in Patients with Chronic Hepatitis C Virus Infection and Effect of Presence of Systemic Disease. EURASIAN JOURNAL OF MEDICINE, 44(3), 131–134. https://doi.org/10.5152/eajm.2012.31
BibTeX
@article{albayrak2012-225073,
author = {Albayrak, Ayşe and Dursun, Hakan and Uyanık, Muhammet Hamidullah and Cerrah, Serkan},
title = {Anti-Cyclic Citrullinated Peptide Frequency in Patients with Chronic Hepatitis C Virus Infection and Effect of Presence of Systemic Disease},
journal = {EURASIAN JOURNAL OF MEDICINE},
year = {2012},
volume = {44},
number = {3},
pages = {131--134},
issn = {1308-8734},
doi = {10.5152/eajm.2012.31},
url = {https://akademik.atauni.edu.tr/yayinlar/225073-anti-cyclic-citrullinated-peptide-frequency-in-patients-with-chronic-hepatitis-c}
}